Capecitabine / Vemurafenib / Bevacizumab combination therapy (Q38836200)

combination therapy

Language	Label	Description	Also known as
English	Capecitabine / Vemurafenib / Bevacizumab combination therapy	combination therapy

Statements

instance of

1 reference

https://civic.genome.wustl.edu/links/evidence/98

stated in

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer

1 reference

https://civic.genome.wustl.edu/links/evidence/98

stated in

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer

1 reference

https://civic.genome.wustl.edu/links/evidence/98

stated in

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer

1 reference

https://civic.genome.wustl.edu/links/evidence/98

stated in

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer

Capecitabine / Vemurafenib / Bevacizumab combination therapy (Q38836200)

Statements

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Capecitabine / Vemurafenib / Bevacizumab combination therapy (Q38836200)

Statements

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search